<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> Dec-31-1996 <PERIOD-END> Sep-30-1996<F1> <CASH> 1368 <SECURITIES> 520 <RECEIVABLES> 2451<F2> <ALLOWANCES> 0 <INVENTORY> 1544 <CURRENT-ASSETS> 6935 <PP&E> 6563 <DEPRECIATION> 2686 <TOTAL-ASSETS> 14005 <CURRENT-LIABILITIES> 4815 <BONDS> 626 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 6295 <TOTAL-LIABILITY-AND-EQUITY> 14005 <SALES> 11110 <TOTAL-REVENUES> 11110 <CGS> 2899 <TOTAL-COSTS> 2899 <OTHER-EXPENSES> 2349 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 54 <INCOME-PRETAX> 3005 <INCOME-TAX> 871 <INCOME-CONTINUING> 2134 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2134 <EPS-PRIMARY> 4.25 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.